Insider Trading & Ownership - Berrey M Michelle

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Berrey M Michelle

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-11-08
Disposition
2023-11-13
2:49 pm
N/A
N/A
INTERCEPT PHARMACEUTICALS INC.ICPTBerrey M Michelle
President, R&D and CMO
51,790$190
(Direct)
View
2023-11-08
Disposition
2023-11-13
2:49 pm
N/A
N/A
INTERCEPT PHARMACEUTICALS INC.ICPTBerrey M Michelle
President, R&D and CMO
134,600$00
(Direct)
View
2023-11-08
Equity Swap
2023-11-13
2:49 pm
N/A
N/A
INTERCEPT PHARMACEUTICALS INC.ICPTBerrey M Michelle
President, R&D and CMO
28,349$190
(Direct)
View
2023-09-14
Tax Withholding
2023-09-18
4:01 pm
N/A
N/A
INTERCEPT PHARMACEUTICALS INC.ICPTBerrey M Michelle
President, R&D & CMO
1,246$11.5780,139
(Direct)
View
2023-06-14
Tax Withholding
2023-06-16
4:01 pm
N/A
N/A
INTERCEPT PHARMACEUTICALS INC.ICPTBerrey M Michelle
President, R&D & CMO
1,246$12.0481,385
(Direct)
View
2023-03-14
Tax Withholding
2023-03-16
4:07 pm
N/A
N/A
INTERCEPT PHARMACEUTICALS INC.ICPTBerrey M Michelle
President, R&D & CMO
1,246$15.7982,631
(Direct)
View
2023-02-15
Option Award
2023-02-17
8:25 pm
N/A
2033-02-15
Ocean Biomedical Inc.OCEABerrey M Michelle
Director
75,000$075,000
(Direct)
View
2023-01-27
Option Award
2023-01-31
4:03 pm
N/A
2033-01-27
INTERCEPT PHARMACEUTICALS INC.ICPTBerrey M Michelle
President, R&D & CMO
38,700$0107,877
(Direct)
View
2022-12-31
Tax Withholding
2023-01-03
4:01 pm
N/A
N/A
INTERCEPT PHARMACEUTICALS INC.ICPTBerrey M Michelle
President, R&D & CMO
765$12.3769,177
(Direct)
View
2022-12-14
Tax Withholding
2022-12-16
4:01 pm
N/A
N/A
INTERCEPT PHARMACEUTICALS INC.ICPTBerrey M Michelle
President, R&D and CMO
1,246$14.9469,942
(Direct)
View
2022-09-14
Tax Withholding
2022-09-16
4:02 pm
N/A
N/A
INTERCEPT PHARMACEUTICALS INC.ICPTBerrey M Michelle
President, R&D and CMO
1,246$17.1471,188
(Direct)
View
2022-06-14
Tax Withholding
2022-06-16
4:01 pm
N/A
N/A
INTERCEPT PHARMACEUTICALS INC.ICPTBerrey M Michelle
President, R&D and CMO
4,984$12.172,434
(Direct)
View
2022-01-27
Option Award
2022-01-31
4:13 pm
N/A
2032-01-27
INTERCEPT PHARMACEUTICALS INC.ICPTBerrey M Michelle
President, R&D and CMO
27,900$095,018
(Direct)
View
2021-06-14
Option Award
2021-06-15
7:01 pm
N/A
2031-06-14
INTERCEPT PHARMACEUTICALS INC.ICPTBerrey M Michelle
President, R&D and CMO
160,118$0160,118
(Direct)
View